Transcode Therapeutics, Inc. (RNAZ) SEC Filings & Financial Intelligence
Transcode Therapeutics, Inc. (RNAZ) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: RNAZ
CIK: 1829635
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
WithumSmith+Brown, PC
Auditor SinceSince 12/31/2020 12:00:00 AM
Lead Engagement PartnerAlexander Dundara
Audit LocationEast Brunswick, New Jersey, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-01 | 2026-10-01 | FORM 8-K | 0001104659-26-112826 | View SEC Doc Filr Page |
| 8-K | 2026-09-28 | 2026-09-28 | FORM 8-K | 0001104659-26-111170 | View SEC Doc Filr Page |
| 3 | 2026-09-21 | 2026-09-10 | OWNERSHIP DOCUMENT | 0001104659-26-109371 | View SEC Doc Filr Page |
| 4 | 2026-09-11 | 2026-09-09 | OWNERSHIP DOCUMENT | 0001104659-26-107120 | View SEC Doc Filr Page |
| 8-K | 2026-09-11 | 2026-09-09 | FORM 8-K | 0001104659-26-107115 | View SEC Doc Filr Page |
| 10-Q | 2026-08-14 | 2026-06-30 | 10-Q | 0001829635-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-08-05 | 2026-08-03 | OWNERSHIP DOCUMENT | 0001104659-26-091078 | View SEC Doc Filr Page |
| 3 | 2026-08-05 | 2026-07-27 | OWNERSHIP DOCUMENT | 0001104659-26-091074 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-08-03 | — | SCHEDULE 13D/A Filing | 0001104659-26-089819 | View SEC Doc Filr Page |
| 8-K | 2026-08-03 | 2026-08-03 | FORM 8-K | 0001104659-26-089805 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-28 | — | SCHEDULE 13G Filing | 0001493152-26-035076 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-28 | — | SCHEDULE 13G Filing | 0001493152-26-035075 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-28 | — | SCHEDULE 13G Filing | 0001493152-26-035074 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-07-27 | — | SCHEDULE 13D/A Filing | 0001104659-26-087098 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-07-23 | — | SCHEDULE 13D/A Filing | 0001104659-26-086266 | View SEC Doc Filr Page |
| 424B3 | 2026-07-20 | — | 424B3 | 0001104659-26-085107 | View SEC Doc Filr Page |
| 424B3 | 2026-07-20 | — | 424B3 | 0001104659-26-085105 | View SEC Doc Filr Page |
| 8-K | 2026-07-20 | 2026-07-20 | FORM 8-K | 0001104659-26-085073 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-07-17 | — | SCHEDULE 13D/A Filing | 0001104659-26-084636 | View SEC Doc Filr Page |
| DEFA14A | 2026-07-17 | — | DEFA14A | 0001104659-26-084628 | View SEC Doc Filr Page |
| 8-K | 2026-07-17 | 2026-07-16 | FORM 8-K | 0001104659-26-084617 | View SEC Doc Filr Page |
| 8-K | 2026-07-02 | 2026-07-02 | FORM 8-K | 0001104659-26-080311 | View SEC Doc Filr Page |
| 8-K | 2026-06-18 | 2026-06-18 | FORM 8-K | 0001104659-26-075440 | View SEC Doc Filr Page |
| 8-K | 2026-06-03 | 2026-06-03 | FORM 8-K | 0001104659-26-069810 | View SEC Doc Filr Page |
| ARS | 2026-06-02 | 2025-12-31 | ARS | 0001104659-26-069488 | View SEC Doc Filr Page |